Objectives:
1)To give the learner current recommendations for PRIMARY and SECONDARY prevention.
2) To help the learner assimilate these recommendations into their current practice patterns.
3) Describe the concept of TERTIARY prevention. 
I)Why Preventative

So what is the problem?
The problem is that we don=t know what to do with localized disease.
Why don=t we know what to do?
Here is why: Prostate Cancer continuing: -localized prostate cancer (T 0-2) followed without 5 year survival -98% 10 year survival -87%
-extra prostatic disease (T 3-4) 41 5 year survival -51% 10 year survival -0% -doubling time of early prostate ca. is 3 years 
HOW GOOD ARE OUR TESTS?
Test Positive predictive value
QUESTIONS WE MUST ANSWER
What ages do we screen? How do we screen them ?
We limit our screening to the groups we can help the most. 
PSA, DRE & Prostate Cancer Screening
Two groups based on treatment options :
Group 1 (Age > 70) or ( age < 70 with < l0 years life expectancy) 45 Localized disease º no treatment. Metastatic disease º anti-androgen or chemotherapy Group 2 (Age < 70 with > 10 years life expectancy)
Localized disease(T 0-2) .
Treatment: º Surgical, Anti-androgens, Radiation therapy Metastatic disease(T3-4) Treatment º Surgical, Anti-androgens, Radiation 6
Confusing fact---------Up til now -PSAscreening º no reduction in mortality, morbidity ºno improvement in quality of life 46 
BUT NOT ALL THE VOTES ARE IN !!!!!
New Data -age 50-80, screened annually (N = 7,155) over 7 years -all with PSA > 3.O received TRUS and biopsy, -of positives biopsies (N=367): 92% received treatment which gave a 69% reduction in prostate cancer mortality in screened 47 Treatment type distribution: Antiandrogen plus -radical prostatectomy -46% Antiandrogen plus -radiation -32% Antiandrogen alone -15% 7 ***************************************************************************** 
THE CURRENT RECOMMENDATIONS
PSA
III)Primary Prevention:
V) TERTIARY PREVENTION
1)VISION TEST-2)HEARING -----------WHISPER TEST 3)UPPER/LOWER EXTREMITY FUNCTION 4)MENTAL STATUS
G)Prostate Cancer: Recs:------------DRE/PSA---------º 50 y.o.(ACS)-------------annually (Discontinue after age 70 or with < 10 yrs life expectancy) H) Exercise:
Recs 
-----------prevention of CAD in (men)&prevention of osteoporosis(all) I)Immunizations:Tetanus-diptheria--------dT booster------------------------------
PSA, DRE & Prostate Cancer Screening
Two groups based on treatment options : (Age < 70 with > 10 years life expectancy)
Treatment:--Surgical, Anti-androgens, Radiation therapy Metastatic disease(T3-4) Treatment---Surgical, Anti-androgens, Radiation (Age > 70) or( age <70 with < l0 years life expectancy)--localized disease-----no treatment. metastatic diseaseCanti-androgen or chemotherapy *************************************************************************** PSA LEVELS : 
